Exogenous Bradykinin Inhibits Tissue Factor Induction and Deep Vein Thrombosis via Activating the eNOS/Phosphoinositide 3-Kinase/Akt Signaling Pathway
Author(s) -
Ruolan Dong,
Wenshu Chen,
Wenjing Feng,
Congying Xia,
Danli Hu,
Yanjun Zhang,
Yan Yang,
Dao Wen Wang,
Xizhen Xu,
Ling Tu
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000438526
Subject(s) - bradykinin , umbilical vein , protein kinase b , medicine , signal transduction , tissue factor , pi3k/akt/mtor pathway , endocrinology , chemistry , pharmacology , biology , microbiology and biotechnology , receptor , in vitro , biochemistry , coagulation
Bradykinin has been shown to exert a variety of protective effects against vascular injury, and to reduce the levels of several factors involved in the coagulation cascade. A key determinant of thrombin generation is tissue factor (TF). However, whether bradykinin can regulate TF expression remains to be investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom